Skip to content

Biofilm on Chest Drains After Thoracic Surgery: Clinical Impact and Antibiotic Resistance

Biofilm Formation on Thoracic Drains: Clinical Significance and Association With Antibiotic Resistance

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07228598
Enrollment
180
Registered
2025-11-14
Start date
2025-10-01
Completion date
2026-10-01
Last updated
2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic Resistance, Bacterial, Biofilms, Postoperative Infection, Thoracic Surgery

Brief summary

This prospective observational study aims to investigate the frequency and clinical significance of biofilm formation on thoracic chest drains used after thoracic surgery. Biofilms are structured bacterial communities that adhere to surfaces and can promote infection and antibiotic resistance. In this study, small samples from the tips of chest drains will be collected under sterile conditions at the time of drain removal and analyzed in the microbiology laboratory. The main objectives are to evaluate the relationship between the duration of chest drain placement and the presence of biofilm, and to identify the antibiotic resistance profiles of microorganisms isolated from these biofilms. Secondary outcomes include the association between biofilm formation, postoperative infections (such as empyema or wound infection), and the length of hospital stay. This study will be conducted at Ondokuz Mayıs University Faculty of Medicine, Department of Thoracic Surgery, in collaboration with the Department of Microbiology. The findings are expected to contribute to better understanding of optimal drain management and infection prevention strategies after thoracic surgery.

Interventions

OTHERChest Drain Tip Sampling

No active intervention; routine chest drain removal followed by microbiological and biofilm analysis of drain tip samples.

Sponsors

Caner İşevi, MD
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years and older * Undergoing elective thoracic surgery requiring chest drain placement * Able and willing to provide written informed consent

Exclusion criteria

* Presence of active infection prior to surgery * Emergency thoracic surgery * Immunosuppressed patients (e.g., neutropenia, advanced malignancy, organ transplantation) * Patients receiving systemic antibiotic therapy at the time of drain removal * Drainage for empyema or pre-existing pleural infection * Presence of extrathoracic infection focus * Refusal or inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Presence and Intensity of Biofilm Formation on Chest Drain TipsAt the time of chest drain removal (postoperative days 1-7)Biofilm formation on the inner surface of chest drain tips will be evaluated using a microplate crystal violet staining method. The optical density (OD) at 492 nm will be measured, and biofilm intensity will be classified according to the Christensen and Chusri scale (non, weak, moderate, strong). The proportion of patients with biofilm-positive drain tips will be recorded and compared across drain duration groups.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026